GLP-1 RA: glucagon-like peptide-1 receptor agonist; BMI: body mass index; T2D: type 2 diabetes; SAEs: serious adverse events; CVD: cardiovascular disease; RCT: randomized controlled trial; GI: gastrointestinal. This evidence concerns the gene GLP1R and cardiovascular disorder.